PURPOSE:
This feasibility trial studies how well the Optune device works in treating younger patients with recurrent/refractory/progressive supratentorial malignant glioma and ependymoma. The TTFields generated by Optune device may inhibit the growth of tumor.
DETAILED DESCRIPTION:
Primary Objectives:
Study Type: Interventional
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
AGES ELIGIBLE FOR STUDY: 1 year to 90 Years
ELIGIBILITY CRITERIA
Inclusion Criteria:
Exclusion Criteria: